SEC filing record
Primary Source · SEC.gov

Clene Inc.

2024 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalNew Form D filerForm D · 2024-10-09Last filing 2024-10-09

Raised

$7M

Investors

13

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Clene Inc. is a Delaware corporation that filed a Form D with the SEC on October 9, 2024 in the Pharmaceuticals industry group. The offering claims Rule 506(b) and covers equity. Clene Inc. reported $7,310,060 sold from 13 investors of a $7,310,060 total offering as of the Form D filed October 9, 2024. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names Canaccord Genuity LLC (CRD 1020), associated with None as the recipient of sales compensation soliciting in AR, CT, DE, FL, MA, MD, NJ, NY, UT. Sales commissions are reported as $436,630 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 6550 South Millrock Drive, Suite G50, Salt Lake City, UT 84121.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001822791
Entity NameClene Inc.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationDelaware
Issuer Address6550 South Millrock Drive, Suite G50, Salt Lake City, UT 84121
Phone(801) 676-9695
Former NamesChelsea Worldwide Inc. (until December 18, 2020)
Industry / Fund TypePharmaceuticals
Securities TypeEquity
First Sale DateOctober 1, 2024
Filing DateOctober 9, 2024
Accession Number0001822791-24-000002
Total Offering Amount$7,310,060
Total Amount Sold$7,310,060
Amount Remaining$0
Total Investors13
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Sales Commissions$436,630 (to Canaccord Genuity LLC)
Finders' Fees$0
Revenue RangeDecline to Disclose
State (Issuer Address)UT
Amendment Count2 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

1

latest Oct 9, 2024

Critical / warning

0 / 0

0 watch · 1 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

2

closed

Latest event New filer · Oct 9, 2024

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 1 filing event with values and deltas, latest 2024-10-09, and alerts on the next one
  • 2 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Item 3 changed on the Form D filed 2024-10-09: 4 related persons added and 5 removed against the filing of 2021-05-26; 11 now listed. The names are in the Terminal feed.

Robert Dee Etherington

Executive Officer, Director · Salt Lake City, UT

Morgan Dee Brown

Executive Officer · Salt Lake City, UT

Mark Dee Mortenson

Executive Officer · Salt Lake City, UT

David Dee Matlin

Director · Salt Lake City, UT

Alison Dee Mosca

Director · Salt Lake City, UT

Arjun Dee Desai

Director · Salt Lake City, UT

Vallerie V. McLaughlin

Director · Salt Lake City, UT

Matthew V. Kiernan

Director · Salt Lake City, UT

Reed Neil Wilcox

Director · Salt Lake City, UT

Jonathon T. Gay

Director · Salt Lake City, UT

Shalom T. Jacobovitz

Director · Salt Lake City, UT

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

Canaccord Genuity LLCCRD 1020 on BrokerCheck

Associated broker-dealer: None · New York, NY · Soliciting in AR, CT, DE, FL, MA, MD, NJ, NY, UT

Questions About Clene Inc.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Clene Inc.?

Clene Inc. is a Delaware corporation that filed a Form D with the SEC on October 9, 2024 in the Pharmaceuticals industry group. The filing claims Rule 506(b) for an offering of equity.

Is Clene Inc. legit?

AltStreet does not rate legitimacy; it reports the public record. Clene Inc. filed a Form D with the SEC on October 9, 2024 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $7,310,060 sold to 13 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Clene Inc. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Clene Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Clene Inc. raised?

Clene Inc. reported $7,310,060 sold from 13 investors of a $7,310,060 total offering as of the Form D filed October 9, 2024.

Who can invest in Clene Inc.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in Clene Inc.?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling Clene Inc. and how are they paid?

The Form D names Canaccord Genuity LLC (CRD 1020), associated with None as the recipient of sales compensation soliciting in AR, CT, DE, FL, MA, MD, NJ, NY, UT. Sales commissions are reported as $436,630 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Clene Inc.?

The Form D lists 11 related persons: Robert Dee Etherington, executive officer, director; Morgan Dee Brown, executive officer; Mark Dee Mortenson, executive officer; David Dee Matlin, director; Alison Dee Mosca, director; Arjun Dee Desai, director; Vallerie V. McLaughlin, director; Matthew V. Kiernan, director, and 3 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Clene Inc. located?

The issuer's address on its SEC filings is 6550 South Millrock Drive, Suite G50, Salt Lake City, UT 84121. Its phone number of record is 801-676-9695. It is organized under the laws of Delaware.

How long is the Clene Inc. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is Clene Inc.'s revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.